Researchers at the University of Liverpool have found that the weight-loss drug tirzepatide is associated with a significantly reduced risk of developing type 2 diabetes (T2D).
Medical Xpress – latest medical and health news stories
Posted inHealth Care
Study sees potential benefits of obesity drug tirzepatide in tackling type 2 diabetes
Posted by
No Comments
No Comments
